Blar i forfatter "Henriksen, Ben Tore"
-
Clinical pharmacist intervention to improve medication safety for hip fracture patients through secondary and primary care settings: a nonrandomised controlled trial
Henriksen, Ben Tore; Krogseth, Maria; Andersen, Randi D.; Nordsveen, Maren; Nguyen, Caroline Thy; Mathiesen, Liv; Andersson, Yvonne (Journal article; Tidsskriftartikkel; Peer reviewed, 2023-06-13)Background: Hip fracture patients face a patient safety threat due to medication discrepancies and adverse drug reactions when they have a combination of high age, polypharmacy and several care transitions. Consequently, optimised pharmacotherapy through medication reviews and seamless communication of medication information between care settings is necessary. The primary aim of this study was to ... -
Medication management for patients with hip fracture at a regional hospital and associated primary care units in Norway: a descriptive study based on a survey of clinicians' experience and a review of patient records
Henriksen, Ben Tore; Krogseth, Maria; Thy Nguyen, Caroline; Mathiesen, Liv; Davies, Maren Nordsveen; Andersen, Randi Dovland; Andersson, Yvonne (Journal article; Tidsskriftartikkel; Peer reviewed, 2022-11-15)Objective: Patients with hip fracture are at high risk of medication errors due to a combination of high age, comorbidities, polypharmacy and several care transitions after fracture. The aim was to study medication management tasks concerning patient safety: medication reconciliation, medication review and communication of key medication information in care transitions. Design: Descriptive study ... -
Supply and administration of denosumab for patients with osteoporosis in primary care - a qualitative study to explore the potential for pharmacy practice development
Henriksen, Ben Tore (Master thesis; Mastergradsoppgave, 2013-05-20)BACKGROUND: Denosumab is a medication for postmenopausal osteoporosis delivered as a subcutaneous injection. Within the National Health Service (NHS) Lothian, Scotland, the treatment is currently administered in a hospital setting. Feedback from patients and staff indicate that the drug could most likely be delivered in a community setting, which is in accordance with Scottish Government policy ...